Risk-based screening
New risk model vastly improves breast cancer detection for younger high-risk women
Anonymous
Key Points
1
Using the Boadicea/BOADICEA model, eight times as many women under 50 would be identified for referral compared with NICE criteria, expanding the pool of women flagged for further assessment.
2
Only about 4.4% of women under 50 who went on to develop breast cancer within 10 years would have been referred for tests under NICE guidelines, highlighting substantial under-referral by the current criteria.
3
The BOADICEA risk assessment is implemented via the CanRisk platform and integrates family history, lifestyle, reproductive history, and genetics to provide a more comprehensive risk profile.
4
The study drawing these comparisons analyzed data from 1,258 women under 50 who participated in the Breast Cancer Now Generations Study between 2004 and 2011.
5
The research was published in the British Journal of Cancer, underscoring the formal, peer-reviewed nature of these findings.
Current NHS referral guidelines miss up to 95% of women under 50 who will develop breast cancer within a decade, according to new research from the University of Cambridge, published in the British Journal of Cancer. Only about 4.4% of high-risk younger women would be flagged for further tests under existing National Institute for Health and Care Excellence (NICE) criteria, the study found ITV News.
Researchers say a smarter screening tool — one that factors in family history, genetics, and lifestyle — could identify eight times more at-risk women. The findings have reignited calls for Britain to move away from age-based screening toward a personalised, risk-based approach Yahoo News UK.
How NICE Guidelines Are Leaving Young Women Behind
NICE tells GPs to refer women for breast cancer checks based largely on age and a narrow set of risk factors. But the Cambridge study found this approach is badly inadequate for under-50s. Of 1,258 women under 50 tracked in the Breast Cancer Now Generations Study between 2004 and 2011, just 4.4% of those who later developed breast cancer would have been referred under current NICE rules ITV News.
That means roughly 95 out of every 100 younger women heading toward a breast cancer diagnosis are not flagged in time. Many receive no monitoring at all until they notice symptoms themselves — by which point the cancer may be harder to treat Yahoo News UK.
BOADICEA Model Could Catch Far More Cases Early
The Cambridge team tested an alternative tool called BOADICEA, available on a platform called CanRisk. It combines family history, reproductive history, lifestyle factors, and genetics — including polygenic risk scores, which measure inherited genetic risk across many genes. When applied to all women under 50, it would flag about 26.5% as above-average risk and refer them for further checks Yahoo News Canada.
That wider net would capture roughly 34–35% of all future breast cancer cases in this age group. Researchers say that is a dramatic improvement over the current system. The BOADICEA approach would also identify eight times as many women for referral compared to NICE guidelines ITV News.
Scientists Urge an Urgent Rethink of Screening Policy
Researchers are calling on health authorities to review clinical policy now. The findings align with broader calls at the NCRI cancer conference for a shift to risk-stratified screening across the UK. The message is consistent: age alone is a poor predictor of who needs early intervention Streamline Feed.
The study's authors stress that better risk tools already exist and are ready to use. The BOADICEA model is already implemented in the CanRisk platform and could be rolled out to GPs with relatively little disruption. Every year of delay, they warn, means more younger women are diagnosed too late Yahoo News UK.
What Risk-Based Screening Would Actually Look Like
Under a risk-stratified system, GPs would run every woman under 50 through a tool like BOADICEA before deciding on next steps. Women flagged as high risk would get earlier mammograms, genetic testing, or specialist referrals. Women at lower risk could avoid unnecessary procedures. It is a more tailored model than the current one-size-fits-all approach Yahoo News Canada.
Polygenic risk scores — a measure of risk based on hundreds of small genetic variants — are a key part of this shift. As these scores become cheaper and faster to generate, experts say there is no good reason to keep relying on age and basic family history alone. The Cambridge researchers say updating the guidelines could save lives at relatively low cost ITV News.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
30
Articles
34
Reach
64
Topics
A
AnonymousAuthor
